RSC Advances
Paper
(26), 156 (20), 91 (74), 57 (82), 43 (100). For C22H15N3O4 (385.37): 35.3, 86.1, 119.5, 124.0, 126.5, 126.9, 130.0 (2CH), 131.4, 131.6
C, 68.57; H, 3.92; N, 10.90; O, 16.61; found: C, 68.81; H, 3.75; N, (2CH), 132.5, 134.3, 135.2, 139.0, 151.0, 155.2, 156.3, 164.3,
10.91.
181.8, 186.6. MS (EI, 70 eV): m/z (%): 477 (M+, 5), 338 (22), 321
5-m-Tolylbenzo[G]pyrimido[4,5-b]quinoline-2,4,6,11(1h,3h, (32), 235 (100), 156 (76), 76 (80). For C23H16BrN3O4 (478.29): C,
5h,12h)-tetraone (4f). Red powder; mp 282 ꢀC. IR (KBr) (nmax
/
57.76; H, 3.37; N, 8.79; found: C, 57.86; H, 3.35; N, 8.83.
1
cmꢂ1): 3327, 3266, 3051, 1723, 1655, 1612, 1525. H NMR (400
1,3-Dimethyl-5-m-tolylbenzo[G]pyrimido[4,5-b]quinoline-
MHz, DMSO-d6): dH (ppm) 2.70 (s, 3H, Me), 5.21 (s, 1H, CH), 2,4,6,11(1h,3h,5h,12h)-tetraone (4k). Red powder; mp 195 ꢀC. IR
7.01–8.12 (m, 8H, H-Ar), 9.25 (s, 1H, NH), 10.15 (s, 1H, NH), (KBr) (nmax/cmꢂ1): 3325, 1705, 1656, 1570, 1520. H NMR (400
1
10.83 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): dC (ppm) 23.5, MHz, DMSO-d6): dH (ppm) 2.22 (s, 3H, Me), 3.14 (s, 3H, NMe),
35.5, 86.4, 117.5, 124.1, 126.4, 126.9, 127.3, 128.0, 128.6, 131.5, 3.36 (s, 3H, NMe), 5.80 (s, 1H, CH), 6.94–8.02 (m, 8H, H-Ar),
132.5, 134.3, 135.3, 135.6, 138.0, 139.4, 151.5, 160.2, 163.3, 13.06 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): dC (ppm)
181.9, 183.5. MS (EI, 70 eV): m/z (%): 385 (M+, 8), 294 (40), 214 22.0, 29.0, 31.2, 35.5, 86.7, 111.8, 124.6, 126.5, 126.9, 127.2,
(22), 156 (28), 91 (70), 57 (78), 43 (100). For C22H15N3O4 (385.37): 128.0, 128.8, 131.4, 132.6, 134.3, 135.3, 135.4, 137.9, 139.1,
C, 68.57; H, 3.92; N, 10.90; found: C, 68.70; H, 3.85; N, 10.86.
151.0, 155.2, 164.5, 181.9, 184.3. MS (EI, 70 eV): m/z (%): 413
5-p-Tolylbenzo[G]pyrimido[4,5-b]quinoliꢀne-2,4,6,11(1h,3h, (M+, 8), 275 (16), 257 (22), 235 (100). For C24H19N3O4 (413.43): C,
5h,12h)-tetraone (4g). Red powder; mp 311 C. IR (KBr) (nmax
/
69.72; H, 4.63; N, 10.16; found: C, 69.86; H, 4.53; N, 10.05.
1
cmꢂ1): 3401, 3254, 3059, 1713, 1655, 1608, 1515. H NMR (400
1,3-Dimethyl-5-p-tolylbenzo[G]pyrimido[4,5-b]quinoline-
MHz, DMSO-d6): dH (ppm) 2.18 (s, 3H, Me), 5.05 (s, 1H, CH), 2,4,6,11(1h,3h,5h,12h)-tetraone (4l). Red powder; mp 263 ꢀC. IR
7.01 (d, 3JHH ¼ 7.7 Hz, 2H), 7.19 (d, 3JHH ¼ 7.7 Hz, 2H), 7.79–8.05 (KBr) (nmax/cmꢂ1): 3356, 1721, 1655, 1565. H NMR (400 MHz,
1
(m, 4H, H-Ar), 9.20 (s, 1H, NH), 10.13 (s, 1H, NH), 10.88 (s, 1H, DMSO-d6): dH (ppm) 2.26 (s, 3H, Me), 3.10 (s, 3H, NMe), 3.32 (s,
NH). 13C NMR (100 MHz, DMSO-d6): dC (ppm) 21.0, 35.3, 86.5, 3H, NMe), 5.51 (s, 1H, CH), 6.98 (d, 3JHH ¼ 7.8 Hz, H-Ar), 7.20 (d,
114.9, 126.7, 126.8, 129.0 (2 CH), 130.5 (2 CH), 130.8, 131.3, 3JHH ¼ 7.9 Hz, H-Ar), 7.75–8.04 (m, 4H, H-Ar), 9.03 (s, 1H, NH).
132.5, 134.3, 135.8, 138.8, 144.4, 148.7, 159.2, 163.4, 179.8, 13C NMR (100 MHz, DMSO-d6): dC (ppm) 22.2, 28.9, 31.5, 36.5,
183.1. MS (EI, 70 eV): m/z (%): 385 (M+, 5), 294 (45), 214 (30), 156 88.7, 116.0, 124.3, 126.5, 126.9, 128.8 (2CH), 130.7 (2CH), 131.6,
(20), 76 (78), 57 (82), 43 (100). For C22H15N3O4 (385.37): C, 68.57; 134.5, 135.3, 135.4, 136.9, 139.4, 151.0, 158.2, 163.5, 180.7,
H, 3.92; N, 10.90; found: C, 68.50; H, 3.87; N, 10.81.
184.1. MS (EI, 70 eV): m/z (%): 413 (M+, 10), 322 (6), 275 (20), 235
5-(4-Methoxyphenyl)benzo[G]pyrimido[4,5-b]quinoline-2,4, (100), 156 (72), 76 (80). For C24H19N3O4 (413.43): C, 69.72; H,
6,11(1h,3h,5h,12h)-tetraone (4h). Orange powder; mp 301 ꢀC. IR 4.63; N, 10.16; found: C, 69.78; H, 4.45; N, 10.21.
(KBr) (nmax/cmꢂ1): 3429, 3176, 3054, 1704, 1679, 1609, 1532. 1H
NMR (400 MHz, DMSO-d6): dH (ppm) 3.64 (s, 3H, OMe), 5.01 (s,
Acknowledgements
1H, CH), 6.75 (d, 3JHH ¼ 7.7 Hz, 2H, H-Ar), 7.20 (d, 3JHH ¼ 7.6 Hz,
2H, H-Ar), 7.80–8.02 (m, 4H, H-Ar), 9.30 (s, 1H, NH), 10.16 (s, P. Rai and Rahila thanks to CSIR for their Senior Research
1H, NH), 10.90 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): dC Fellowship. H. Sagir thanks to UGC for her Junior Research
(ppm) 32.5, 55.7, 86.5, 114.3 (2 CH), 124.4, 126.2, 126.7, 129.7, Fellowship. Authors gratefully acknowledge the SAIF, Punjab
130.1, 130.5, 133.1, 133.2, 133.7, 135.3, 137.9 (2 CH), 144.7, University, Chandigarh, for providing all the spectroscopic data
159.2, 163.4, 179.8, 183.0. MS (EI, 70 eV): m/z (%): 401 (M+, 15), and Nanotechnology Application Centre, University of Allaha-
358 (14), 325 (30), 230 (26), 156 (22), 57 (76), 43 (100). For bad for powder XRD and EDS.
C
22H15N3O5 (401.37): C, 65.83; H, 3.77; N, 10.47; found: C, 65.87;
H, 3.75; N, 10.59.
Notes and references
5-(4-Chlorophenyl)-1,3-dimethylbenzo[G]pyrimido[4,5-b]-
quinoline-2,4,6,11(1h,3h,5h,12h)-tetraone (4i). Orange powder;
1 (a) T. H. Istvan and T. A. Paul, Chem. Rev., 2007, 107, 2167; (b)
P. Rai, M. Srivastava, J. Singh and J. Singh, RSC Adv., 2013, 3,
18775.
2 (a) P. D. Maria, A. Fontana, C. Gasbarri and G. Siani,
Tetrahedron, 2005, 61, 7176; (b) T. Dwars, E. Paetzold and
G. Oehme, Angew. Chem., Int. Ed., 2005, 44, 7174; (c)
M. Srivastava, J. Singh, S. B. Singh, K. Tiwari, V. K. Pathak
and J. Singh, Green Chem., 2012, 14, 901.
mp 251 C. IR (KBr) (nmax/cmꢂ1): 3401, 1715, 1653, 1580, 1516.
ꢀ
1H NMR (400 MHz, DMSO-d6): dH (ppm) 3.18 (s, 3H, NMe), 3.35
(s, 3H, NMe), 5.64 (s, 1H, CH), 7.11–7.89 (m, 8H, H-Ar), 13.10 (s,
1H, NH). 13C NMR (100 MHz, DMSO-d6): dC (ppm) 29.0, 31.3,
35.3, 86.1, 118.9, 124.1, 126.7, 126.9, 130.3 (2CH), 131.4, 131.5
(2CH), 132.6, 134.3, 135.2, 138.9, 151.1, 155.2, 156.4, 164.3,
181.6, 186.6. MS (EI, 70 eV): m/z (%): 433 (M+, 5), 322 (8), 271
(30), 235 (100), 156 (72), 76 (82), 57 (26). For C23H16ClN3O4
(433.84): C, 63.67; H, 3.72; Cl, 8.17; N, 9.69; found: C, 63.84; H,
3.55; N, 8.28.
3 Y. Zhang, Y. Chen, P. Westerhoff, K. Hristovski and
J. C. Crittenden, Water Res., 2008, 42, 2204.
4 (a) P. Rai, M. Srivastava, J. Singh and J. Singh, New J. Chem.,
2014, 38, 3181; (b) J. A. Gladysz, Pure Appl., ed. U. M.
Lindstorm, Wiley-Blackwell, New York, NY, 2007; (c)
M.-O. Simon and C. J. Li, Chem. Soc. Rev., 2012, 41, 1415.
5 (a) J. A. Gladysz, Chem. Rev., 2002, 102, 321; (b) R. M. Singh,
N. Sharma, R. Kumar, M. Asthana and S. Upadhyay,
Tetrahedron, 2012, 68, 10318; (c) Y. M. Elkholy and
5-(4-Bromophenyl)-1,3-dimethylbenzo[G]pyrimido[4,5-b]-
quinoline-2,4,6,11(1h,3h,5h,12h)-tetraone (4j). Orange powder;
mp 229 C. IR (KBr) (nmax/cmꢂ1): 3395, 1700, 1656, 1573, 1512.
ꢀ
1H NMR (400 MHz, DMSO-d6): dH (ppm) 3.12 (s, 3H, NMe), 3.36
(s, 3H, NMe), 5.79 (s, 1H, CH), 7.19–7.9 (m, 8H, H-Ar), 13.16 (s,
1H, NH). 13C NMR (100 MHz, DMSO-d6): dC (ppm) 29.1, 31.3,
27608 | RSC Adv., 2015, 5, 27603–27609
This journal is © The Royal Society of Chemistry 2015